Counterpoint非投资等级趋势ETF HYTR 深 沪
已收盘 04-02 16:00:00 美东时间
21.3151
+0.010
+0.05%
华盛通- 最 高21.335
- 今 开21.29
- 成交量 8.78万股
- 最 低 21.28
- 昨 收 21.305
- 总市值 2.50亿
- 52周最高 21.7361
- 市盈率 静 --
- 换手率 0.75%
- 52周最低 19.8073
- 委 比 0.00%
- 总股本 1174.84万
- 历史最高 22.2822
- 量 比 0.85
- 振 幅 0.26%
- 历史最低 15.9284
- 每 手 1
- 风险率 0.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Primech AI Announces Distribution Agreement To Expand HYTRON Into South Korea, Expected To Generate ~$4.08M In Projected Revenue Over Three Years
Primech AI Pte. Ltd. ("Primech AI" or the "Company"), a subsidiary of Primech Holdings Limited (NASDAQ:PMEC), today announced a distribution agreement to expand HYTRON into South Korea, a partnership expected to generate
03-23 22:09
What's Behind The Jump In Primech Holdings?
Primech Holdings shares are trading higher after securing about $33 million in multi-year service contracts with a Singaporean university.
03-06 04:23
BRIEF-Primech AI Plans Production Of 300 Hytron Robots
May 8 (Reuters) - Primech Holdings Ltd PMEC.O: PRIMECH AI PLANS PRODUCTION OF 300 HYTRON ROBOTS THROUGH ITS CHINA MANUFACTURING EXPANSION Source text: ID:nGNX7hDcz3 Further company coverage: PMEC.O ((...
2025-05-08 23:06
BRIEF-Argenx Announces FDA Approval Of Vyvgart Hytrulo Prefilled Syringe For Self-Injection In Generalized Myasthenia Gravis And Chronic Inflammatory Demyelinating Polyneuropathy
April 10 (Reuters) - argenx SE ARGX.BR: ARGENX ANNOUNCES FDA APPROVAL OF VYVGART HYTRULO PREFILLED SYRINGE FOR SELF-INJECTION IN GENERALIZED MYASTHENIA GRAVIS AND CHRONIC INFLAMMATORY DEMYELINATING PO...
2025-04-11 05:52
CP High Yield Trend ETF declares monthly distribution of $0.0574
CP High Yield Trend ETF (NYSEARCA:HYTR) - $0.0574. Payable Aug 20; for shareholders of record Aug 15; ex-div Aug 15. More on Northern Lights Fund Trust III - CP High Yield Trend ETF Seeking Alpha’s Qu...
2024-08-19 20:58
